We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
35 result(s) found, displaying 11 to 20
-
Australian public assessment report (AusPar)New AusPAR for Vaxelis (DTPa5-Hep B-IPV-Hib) for primary and booster vaccination.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABEVMY bevacizumab 100 mg/4 mL concentrate injection for solution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HULIO adalimumab (rch) 20 mg/0.4 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NEPEXTO etanercept 25 mg in 0.5 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NEPEXTO etanercept 50 mg in 1.0 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONGENTYS opicapone 50 mg hard capsule blister pack.
-
Prescription medicine decision summaryTGA Decision: Vaxelis (DTPa5-HB-IPV-Hib) is approved as a vaccine for diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and Hib.